摘要
目的:观察通络消癥汤治疗乙肝肝硬化代偿期肝郁脾虚夹瘀证临床疗效。方法:将136例肝郁脾虚夹瘀证乙肝肝硬化代偿期患者分为两组各68例。治疗组给予通络消癥汤治疗,对照组给予常规西医治疗,对比两组的临床疗效。结果:治疗组患者HA、LN、CIV及PCⅢ水平以及中医症状总积分均明显低于对照组(P﹤0.05);治疗组总有效率为97.06%,明显高于对照组的86.76%(P﹤0.05)。结论:通络消癥汤治疗肝郁脾虚夹瘀证乙肝肝硬化代偿期患者,可改善患者临床症状。
Objective:To observe the clinical effect of Tongluo Xiaozheng decoction on hepatitis B compensated cirrhosis with syndrome of liver-stagnation and spleen-deficiency with blood stasis. Methods:136 cases of patients with hepatitis B compensated cirrhosis with syndrome of liver-stagnation and spleen-deficiency with blood stasis were randomly divided into two group,68 cases in each group. The treatment group was treated with Tongluo Xiaozheng decoction,while the control group was treated with conventional western medicine. The clinical effects of two groups were compared.Results:After treatment,the levels of HA,LN,CIV and PCIII and the total scores of TCM symptoms of patients in treatment group were significantly lower than those in control group(P<0.05);the total effective rate of treatment group was 97.06%,which was significantly higher than 86.76% of control group(P<0.05). Conclusion:In the treatment of hepatitis B compensated cirrhosis with syndrome of liver-stagnation and spleen-deficiency with blood stasis,Tongluo Xiaozheng decoction can improve the clinical symptoms of patients.
引文
[1]孙晓丽.恩替卡韦对失代偿期乙肝肝硬化的治疗效果探讨[J].中国继续医学教育,2016,8(30):137-138.
[2]崔振利,赵霞,张慧智.乙肝肝硬化治疗中不同核苷类抗病毒药物的应用比较[J].中外医疗,2016,35(3):149-151.
[3]王建国.阿德福韦酯结合微生态制剂用于乙肝肝硬化治疗临床分析[J].当代医学,2016,22(1):78-79.
[4]韩俞,袁雨,刘相波.探讨替比夫定联合阿德福韦酯对活动性乙肝肝硬化长期治疗的效果[J].中国卫生标准管理,2016,7(14):98-99.
[5]Shen Pan,Xiao-Qi Wang,Qi-yong Guo.Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C:T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging[J].World Journal of Gastroenterology,2018,24(18):2 024-2 035.
[6]Woo Hee Cho,Hyun Jae Lee,Ki Bae Bang,et al.Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naive chronic hepatitis B:A case report and review of the literature[J].World Journal of Gastroenterology,2018,24(17):1 919-1 924.
[7]王和木,吴学锋,温梅儿.拉米夫定联合阿德福韦酯对活动性乙肝肝硬化长期治疗的疗效[J].蛇志,2016,28(1):54-55.